← Back to patent-cliff list
CAS 190662-30-7
[(8S,13S,14S,17R)-17-Hydroxy-13-methyl-1,2,4,6,7,8,12,13,14,15,16,17-dodecahydrospiro[cyclopenta[a]phenanthrene-3,2'-[1,3]dioxolan]-17-yl]acetonitrile
Codes: (III)90248-6-a
Application context (from source-drug indications)
ContraceptionDienogest/Estradiol ValerateMenorrhagiaDienogest/Estradiol ValerateContraceptive useDienogest/Estradiol ValeratePelvic painDienogest/Estradiol ValerateHeadacheDienogest/Estradiol ValerateDysmenorrhoeaDienogest/Estradiol ValerateContraceptionDienogestEndocrine system disorderDienogestEndometriosisDienogestAdenomyosisDienogestPainDienogest
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Dienogest/Estradiol Valerate | Tier C — Watch / trade | - |
| Dienogest | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
[(8S,13S,14S,17R)-17-Hydroxy-13-methyl-1,2,4,6,7,8,12,13,14,15,16,17-dodecahydrospiro[cyclopenta[a]phenanthrene-3,2'-[1,3]dioxolan]-17-yl]acetonitrile→17-Oxo-estradiene→Acetonitrile anhydrous
[(8S,13S,14S,17R)-17-Hydroxy-13-methyl-1,2,4,6,7,8,12,13,14,15,16,17-dodecahydrospiro[cyclopenta[a]phenanthrene-3,2'-[1,3]dioxolan]-17-yl]acetonitrile→17-Oxo-estradiene→Acetonitrile anhydrous
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.